| Western result: + | | GST
 | GST-LRPPRC (fragment)
 | | | | | | The western blot contains a test lane of ~20ug of a total protein extract from E coli with ~50ng to 500ng of the antigen (GST-antigen fusion protein). The negative control lane is the same except it contains ~50ng to 100 ng of a GST fusion protein of an irrelevant antigen. The blot was probed with a final antisera dilution of 1:1,000. The secondary antibody (Rabbit anti-mouse IgG + IgM, (H+L) horseradish peroxidase conjugated (Pierce)) is used at 1:5,000 dilution. Note, the molecular weight of the band on the western blot does not correspond to the molecular weight of the natural protein because only a fragment of the gene is used and it is fused to GST. | | Antibody Name/Abbreviation: LRPPRC CBI Antibody Core Code: A0682 "Lot" Number: 1 Position: 100(897-996) % Identical Homology of Target to Mouse Protein: 87% (NP_082509.1| leucine-rich PPR motif-containing protein; leucine rich protein LRP130) Molecular Weight of fusion protein: 38 KDa Target sequence used to make this antibody: AFLQTGNYKEAKKIIETPGIRARSARLQWFCDRCVANNQV
ETLEKLVELTQKLFECDRDQMYYNLLKLYKINGDWQRADA
VWNKIQEENVIPREKTLRLL
| | Sequence Name: LRPPRC Full name: leucine-rich PPR motif-containing protein UniGene Number: N.A. Accession Number: NP_573566 Source organism: human ( Homo sapiens ) Full length size (aa): 1394 NCBI information page: click here Full length sequence: MAALLRSARWLLRAGAAPRLPLSLRLLPGGPGRLHAASYLPAARAGPVAG
GLLSPARLYAIAAKEKDIQEESTFSSRKISNQFDWALMRLDLSVRRTGRI
PKKLLQKVFNDTCRSGGLGGSHALLLLRSCGSLLPELKLEERTEFAHRIW
DTLQKLGAVYDVSHYNALLKVYLQNEYKFSPTDFLAKMEEANIQPNRVTY
QRLIASYCNVGDIEGASKILGFMKTKDLPVTEAVFSALVTGHARAGDMEN
AENILTVMRDAGIEPGPDTYLALLNAYAEKGDIDHVKQTLEKVEKSELHL
MDRDLLQIIFSFSKAGYPQYVSEILEKVTCERRYIPDAMNLILLLVTEKL
EDVALQILLACPVSKEDGPSVFGSFFLQHCVTMNTPVEKLTDYCKKLKEV
QMHSFPLQFTLHCALLANKTDLAKALMKAVKEEGFPIRPHYFWPLLVGRR
KEKNVQGIIEILKGMQELGVHPDQETYTDYVIPCFDSVNSARAILQENGC
LSDSDMFSQAGLRSEAANGNLDFVLSFLKSNTLPISLQSIRSSLLLGFRR
SMNINLWSEITELLYKDGRYCQEPRGPTEAVGYFLYNLIDSMSDSEVQAK
EEHLRQYFHQLEKMNVKIPENIYRGIRNLLESYHVPELIKDAHLLVESKN
LDFQKTVQLTSSELESTLETLKAENQPIRDVLKQLILVLCSEENMQKALE
LKAKYESDMVTGGYAALINLCCRHDKVEDALNLKEEFDRLDSSAVLDTGK
YVGLVRVLAKHGKLQDAINILKEMKEKDVLIKDTTALSFFHMLNGAALRG
EIETVKQLHEAIVTLGLAEPSTNISFPLVTVHLEKGDLSTALEVAIDCYE
KYKVLPRIHDVLCKLVEKGETDLIQKAMDFVSQEQGEMVMLYDLFFAFLQ
TGNYKEAKKIIETPGIRARSARLQWFCDRCVANNQVETLEKLVELTQKLF
ECDRDQMYYNLLKLYKINGDWQRADAVWNKIQEENVIPREKTLRLLAEIL
REGNQEVPFDVPELWYEDEKHSLNSSSASTTEPDFQKDILIACRLNQKKG
AYDIFLNAKEQNIVFNAETYSNLIKLLMSEDYFTQAMEVKAFAETHIKGF
TLNDAANSRLIITQVRRDYLKEAVTTLKTVLDQQQTPSRLAVTRVIQALA
MKGDVENIEVVQKMLNGLEDSIGLSKMVFINNIALAQIKNNNIDAAIENI
ENMLTSENKVIEPQYFGLAYLFRKVIEEQLEPAVEKISIMAERLANQFAI
YKPVTDFFLQLVDAGKVDDARALLQRCGAIAEQTPILLLFLLRNSRKQGK
ASTVKSVLELIPELNEKEEAYNSLMKSYVSEKDVTSAKALYEHLTAKNTK
LDDLFLKRYASLLKYAGEPVPFIEPPESFEFYAQQLRKLRENSS
|